March 28, 2013 / 10:35 PM / in 5 years

Pfizer fails to end lawsuit over Bextra, Celebrex safety

March 28 (Reuters) - Pfizer Inc has failed to persuade a federal judge to dismiss a shareholder lawsuit accusing the company of fraudulently misrepresenting the cardiovascular risks associated with its Bextra and Celebrex pain-relieving drugs.

While dismissing some of the shareholders’ claims, U.S. District Judge Laura Taylor Swain in Manhattan said it was premature to dismiss the entire case.

Swain said a reasonable jury could find that Pfizer intended to mislead shareholders through its disclosures about the drugs’ safety.

The plaintiffs are led by the Teachers’ Retirement System of Louisiana, and a class was certified on July 5, 2012.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below